| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
84.0 days
| 11 |
|
108.0 |
mg/dl |
3.6 |
11.94 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67316 |
66 |
| BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
168.0 days
| 11 |
|
99.0 |
mg/dl |
5.4 |
17.91 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67324 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 12 |
|
6.76 |
mU/l |
1.29 |
4.49 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67331 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 10 |
|
6.04 |
mU/l |
1.01 |
3.19 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67334 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 18 |
|
2.73 |
mU/l |
0.43 |
1.83 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67335 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
84.0 days
| 10 |
|
73.75 |
mg/dl |
3.47 |
10.99 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67346 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
84.0 days
| 11 |
|
30.5 |
mg/dl |
1.16 |
3.84 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67352 |
66 |
| BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
168.0 days
| 20 |
|
11.97 |
mg/dl |
0.77 |
3.45 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67366 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
84.0 days
| 10 |
|
8.49 |
mg/dl |
1.16 |
3.66 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67370 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
168.0 days
| 11 |
|
1.37 |
mmol/l |
0.05 |
0.17 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67405 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
168.0 days
| 10 |
|
1.46 |
mmol/l |
0.03 |
0.09 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67412 |
66 |
| BN/Crl |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
84.0 days
| 13 |
|
1.16 |
mmol/l |
0.08 |
0.29 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67417 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
168.0 days
| 11 |
|
1.37 |
mmol/l |
0.07 |
0.23 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67422 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
84.0 days
| 10 |
|
1.32 |
mmol/l |
0.09 |
0.28 |
plasma free fatty acid analysis |
0.0 |
|
plasma free fatty acid |
|
67424 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
168.0 days
| 10 |
|
1.39 |
mmol/l |
0.07 |
0.22 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67427 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
168.0 days
| 11 |
|
1.34 |
mmol/l |
0.08 |
0.27 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67428 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
84.0 days
| 17 |
|
244.0 |
g |
5.0 |
20.62 |
body weighing method |
|
|
|
|
11291 |
66 |
| BN/Crl |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
84.0 days
| 33 |
|
160.0 |
g |
2.0 |
11.49 |
body weighing method |
|
|
|
|
11295 |
66 |
| BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
84.0 days
| 17 |
|
0.88 |
mmol/l |
0.04 |
0.16 |
plasma triglyceride analysis |
0.0 |
|
|
|
67393 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
168.0 days
| 11 |
|
104.4 |
mg/dl |
5.4 |
17.91 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67320 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
168.0 days
| 11 |
|
104.4 |
mg/dl |
3.6 |
11.94 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67326 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 15 |
|
3.45 |
mU/l |
0.72 |
2.79 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67329 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
168.0 days
| 7 |
|
4.32 |
mU/l |
0.86 |
2.28 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67337 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
168.0 days
| 14 |
|
67.18 |
mg/dl |
1.54 |
5.78 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67343 |
66 |
| BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
84.0 days
| 23 |
|
27.41 |
mg/dl |
1.16 |
5.56 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67351 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
168.0 days
| 14 |
|
29.73 |
mg/dl |
1.16 |
4.33 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67355 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
168.0 days
| 10 |
|
34.75 |
mg/dl |
1.16 |
3.66 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67361 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
168.0 days
| 11 |
|
39.38 |
mg/dl |
1.54 |
5.12 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67362 |
66 |
| BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
84.0 days
| 18 |
|
8.88 |
mg/dl |
0.39 |
1.64 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67369 |
66 |
| BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
168.0 days
| 16 |
|
1.22 |
mmol/l |
0.03 |
0.12 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67403 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
168.0 days
| 13 |
|
309.0 |
g |
6.0 |
21.63 |
body weighing method |
|
|
|
|
11293 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
168.0 days
| 16 |
|
209.0 |
g |
3.0 |
12.0 |
body weighing method |
0.0 |
|
|
|
67314 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
168.0 days
| 11 |
TC - (HDL-C and LDL-C) = VLDL-C |
30.12 |
mg/dl |
1.16 |
3.84 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67386 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
84.0 days
| 12 |
|
113.4 |
mg/dl |
5.4 |
18.71 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67317 |
66 |
| BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
168.0 days
| 20 |
|
88.2 |
mg/dl |
3.6 |
16.1 |
intravenous glucose tolerance test |
0.0 |
|
plasma glucose analysis |
0.8 g glucose/kg |
67318 |
66 |
| BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
84.0 days
| 18 |
|
102.6 |
mg/dl |
3.6 |
15.27 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67321 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 15 |
|
7.19 |
mU/l |
1.01 |
3.9 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67327 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 20 |
|
5.47 |
mU/l |
0.72 |
3.22 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67330 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
84.0 days
| 12 |
|
4.32 |
mU/l |
0.43 |
1.5 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67333 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 10 |
|
5.32 |
mU/l |
0.72 |
2.28 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67338 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
168.0 days
| 11 |
|
77.61 |
mg/dl |
2.7 |
8.96 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67344 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
84.0 days
| 11 |
|
65.25 |
mg/dl |
1.54 |
5.12 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67340 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
84.0 days
| 13 |
|
89.58 |
mg/dl |
2.7 |
9.74 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67347 |
66 |
| BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
168.0 days
| 11 |
|
62.16 |
mg/dl |
1.16 |
3.84 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67348 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
168.0 days
| 11 |
|
77.22 |
mg/dl |
2.7 |
8.96 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67350 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
168.0 days
| 10 |
|
67.57 |
mg/dl |
2.7 |
8.55 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67349 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
84.0 days
| 11 |
|
35.14 |
mg/dl |
0.77 |
2.56 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67353 |
66 |
| BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
168.0 days
| 20 |
|
29.73 |
mg/dl |
0.77 |
3.45 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67354 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
168.0 days
| 14 |
|
12.36 |
mg/dl |
0.77 |
2.89 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67367 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
168.0 days
| 11 |
|
16.22 |
mg/dl |
1.16 |
3.84 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67368 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
84.0 days
| 13 |
|
11.58 |
mg/dl |
1.16 |
4.18 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67371 |
66 |
| BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
168.0 days
| 11 |
|
5.79 |
mg/dl |
0.39 |
1.28 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67372 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
84.0 days
| 13 |
|
1.86 |
mmol/l |
0.08 |
0.29 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67410 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
84.0 days
| 12 |
|
1.3 |
mmol/l |
0.11 |
0.38 |
plasma free fatty acid analysis |
0.0 |
|
plasma free fatty acid |
|
67419 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
168.0 days
| 14 |
|
1.32 |
mmol/l |
0.09 |
0.34 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67421 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
84.0 days
| 13 |
|
1.41 |
mmol/l |
0.08 |
0.29 |
plasma free fatty acid analysis |
0.0 |
|
plasma free fatty acid |
|
67425 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
84.0 days
| 11 |
|
234.0 |
g |
5.0 |
16.58 |
body weighing method |
|
|
|
|
11290 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
84.0 days
| 11 |
TC - (HDL-C and LDL-C) = VLDL-C |
22.01 |
mg/dl |
1.54 |
5.12 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67376 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
168.0 days
| 11 |
TC - (HDL-C and LDL-C) = VLDL-C |
25.1 |
mg/dl |
1.54 |
5.12 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67380 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
84.0 days
| 10 |
TC - (HDL-C and LDL-C) = VLDL-C |
30.12 |
mg/dl |
2.32 |
7.33 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67382 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
84.0 days
| 13 |
TC - (HDL-C and LDL-C) = VLDL-C |
38.61 |
mg/dl |
1.93 |
6.96 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67383 |
66 |
| BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
168.0 days
| 19 |
|
0.7 |
mmol/l |
0.03 |
0.13 |
plasma triglyceride analysis |
0.0 |
|
|
|
67390 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
84.0 days
| 11 |
|
0.98 |
mmol/l |
0.05 |
0.17 |
plasma triglyceride analysis |
0.0 |
|
|
|
67388 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
168.0 days
| 11 |
|
0.87 |
mmol/l |
0.04 |
0.13 |
plasma triglyceride analysis |
0.0 |
|
|
|
67392 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
84.0 days
| 10 |
|
1.09 |
mmol/l |
0.09 |
0.28 |
plasma triglyceride analysis |
0.0 |
|
|
|
67394 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
168.0 days
| 10 |
|
0.92 |
mmol/l |
0.07 |
0.22 |
plasma triglyceride analysis |
0.0 |
|
|
|
67397 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
168.0 days
| 8 |
|
192.0 |
g |
4.0 |
11.31 |
body weighing method |
0.0 |
|
|
|
67313 |
66 |
| BN/Crl |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
84.0 days
| 23 |
|
93.6 |
mg/dl |
1.8 |
8.63 |
intravenous glucose tolerance test |
0.0 |
|
plasma glucose analysis |
0.8 g glucose/kg |
67315 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
84.0 days
| 13 |
|
120.6 |
mg/dl |
5.4 |
19.47 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67323 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
male |
168.0 days
| 14 |
|
97.2 |
mg/dl |
3.6 |
13.47 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67319 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
168.0 days
| 10 |
|
100.8 |
mg/dl |
1.8 |
5.69 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67325 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
84.0 days
| 12 |
|
4.03 |
mU/l |
0.72 |
2.49 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67328 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
male |
168.0 days
| 11 |
|
3.31 |
mU/l |
0.43 |
1.43 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67332 |
66 |
| BN/Crl |
plasma insulin level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood insulin amount |
female |
168.0 days
| 10 |
|
7.05 |
mU/l |
1.44 |
4.55 |
intravenous glucose tolerance test |
0.0 |
|
plasma insulin analysis |
|
67336 |
66 |
| BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
84.0 days
| 23 |
|
62.55 |
mg/dl |
1.54 |
7.41 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67339 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
84.0 days
| 12 |
|
81.85 |
mg/dl |
1.93 |
6.69 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67341 |
66 |
| BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
female |
84.0 days
| 18 |
|
66.41 |
mg/dl |
1.93 |
8.19 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67345 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
84.0 days
| 13 |
|
39.38 |
mg/dl |
1.16 |
4.18 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67359 |
66 |
| BN/Crl |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
84.0 days
| 22 |
|
15.06 |
mg/dl |
1.16 |
5.43 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67363 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
84.0 days
| 11 |
|
12.74 |
mg/dl |
1.16 |
3.84 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67364 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
male |
84.0 days
| 12 |
|
17.76 |
mg/dl |
0.77 |
2.67 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67365 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
84.0 days
| 11 |
|
1.36 |
mmol/l |
0.06 |
0.2 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67400 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
168.0 days
| 14 |
|
1.26 |
mmol/l |
0.03 |
0.11 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67404 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
84.0 days
| 10 |
|
1.49 |
mmol/l |
0.08 |
0.25 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67409 |
66 |
| BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
168.0 days
| 8 |
|
1.38 |
mmol/l |
0.03 |
0.08 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67411 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
84.0 days
| 24 |
|
168.0 |
g |
3.0 |
14.7 |
body weighing method |
|
|
|
|
11297 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
84.0 days
| 15 |
|
164.0 |
g |
4.0 |
15.49 |
body weighing method |
|
|
|
|
11296 |
66 |
| BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
84.0 days
| 22 |
TC - (HDL-C and LDL-C) = VLDL-C |
20.85 |
mg/dl |
1.54 |
7.24 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67375 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
84.0 days
| 12 |
TC - (HDL-C and LDL-C) = VLDL-C |
29.73 |
mg/dl |
1.54 |
5.35 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67377 |
66 |
| BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
168.0 days
| 20 |
TC - (HDL-C and LDL-C) = VLDL-C |
21.24 |
mg/dl |
1.54 |
6.91 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67378 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
male |
168.0 days
| 14 |
TC - (HDL-C and LDL-C) = VLDL-C |
25.1 |
mg/dl |
1.93 |
7.22 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67379 |
66 |
| BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
84.0 days
| 18 |
TC - (HDL-C and LDL-C) = VLDL-C |
25.48 |
mg/dl |
1.16 |
4.91 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67381 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
168.0 days
| 10 |
TC - (HDL-C and LDL-C) = VLDL-C |
26.25 |
mg/dl |
2.32 |
7.33 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67385 |
66 |
| BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
84.0 days
| 22 |
|
0.79 |
mmol/l |
0.03 |
0.14 |
plasma triglyceride analysis |
0.0 |
|
|
|
67387 |
66 |
| BN/Crl |
plasma very low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood VLDL cholesterol amount |
female |
168.0 days
| 11 |
TC - (HDL-C and LDL-C) = VLDL-C |
24.71 |
mg/dl |
1.54 |
5.12 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
calculated vldl cholesterol |
67384 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
168.0 days
| 14 |
|
0.93 |
mmol/l |
0.04 |
0.15 |
plasma triglyceride analysis |
0.0 |
|
|
|
67391 |
66 |
| BN/Crl |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
168.0 days
| 10 |
|
0.87 |
mmol/l |
0.05 |
0.16 |
plasma triglyceride analysis |
0.0 |
|
|
|
67396 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
168.0 days
| 11 |
|
1.12 |
mmol/l |
0.07 |
0.23 |
plasma triglyceride analysis |
0.0 |
|
|
|
67398 |
66 |
| BN/Crl |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
female |
168.0 days
| 23 |
|
200.0 |
g |
5.0 |
23.98 |
body weighing method |
0.0 |
|
|
|
67312 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma glucose level |
fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood glucose amount |
female |
84.0 days
| 10 |
|
104.4 |
mg/dl |
10.8 |
34.15 |
intravenous glucose tolerance test |
0.0 |
|
|
0.8 g glucose/kg |
67322 |
66 |
| BN/Crl |
plasma total cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood cholesterol amount |
male |
168.0 days
| 20 |
|
62.93 |
mg/dl |
1.93 |
8.63 |
plasma total cholesterol measurement test |
0.0 |
|
|
|
67342 |
66 |
| BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
84.0 days
| 18 |
|
32.05 |
mg/dl |
1.16 |
4.91 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67357 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
male |
168.0 days
| 11 |
|
36.29 |
mg/dl |
1.16 |
3.84 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67356 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
84.0 days
| 10 |
|
35.14 |
mg/dl |
1.16 |
3.66 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67358 |
66 |
| BN/Crl |
plasma high density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood HDL cholesterol amount |
female |
168.0 days
| 11 |
|
31.27 |
mg/dl |
1.16 |
3.84 |
plasma high-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67360 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
168.0 days
| 10 |
|
6.18 |
mg/dl |
0.77 |
2.44 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67373 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma low density lipoprotein cholesterol level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood LDL cholesterol amount |
female |
168.0 days
| 11 |
|
8.11 |
mg/dl |
0.77 |
2.56 |
plasma low-density lipoprotein-cholesterol measurement test |
0.0 |
|
|
|
67374 |
66 |
| BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
84.0 days
| 20 |
|
1.14 |
mmol/l |
0.04 |
0.18 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid analysis/test |
plasma phospholipid |
67399 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
male |
84.0 days
| 12 |
|
1.49 |
mmol/l |
0.04 |
0.14 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67401 |
66 |
| BN/Crl |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
84.0 days
| 15 |
|
1.44 |
mmol/l |
0.05 |
0.19 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67406 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma phospholipid level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood phospholipid amount |
female |
168.0 days
| 11 |
|
1.6 |
mmol/l |
0.07 |
0.23 |
plasma phospholipid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67413 |
66 |
| BN.GK-(D8Rat29-D8Got130)/Ox |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
84.0 days
| 11 |
|
1.25 |
mmol/l |
0.1 |
0.33 |
plasma free fatty acid analysis |
0.0 |
|
plasma free fatty acid |
|
67418 |
66 |
| BN/Crl |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
male |
168.0 days
| 20 |
|
1.26 |
mmol/l |
0.07 |
0.31 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67420 |
66 |
| BN/Crl |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
84.0 days
| 10 |
|
1.41 |
mmol/l |
0.11 |
0.35 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67423 |
66 |
| BN/Crl |
plasma free fatty acids level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood free fatty acid amount |
female |
168.0 days
| 10 |
|
1.15 |
mmol/l |
0.07 |
0.22 |
plasma free fatty acid analysis |
0.0 |
|
plasma phospholipid |
plasma phospholipid |
67426 |
66 |
| BN/Crl |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
84.0 days
| 26 |
|
237.0 |
g |
5.0 |
25.5 |
body weighing method |
|
|
|
|
11289 |
66 |
| BN/Crl |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
168.0 days
| 15 |
|
313.0 |
g |
4.0 |
15.49 |
body weighing method |
|
|
|
|
11292 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
body weight |
control condition |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
body mass |
male |
168.0 days
| 12 |
|
345.0 |
g |
11.0 |
38.11 |
body weighing method |
|
|
|
|
11294 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
male |
84.0 days
| 12 |
|
0.89 |
mmol/l |
0.06 |
0.21 |
plasma triglyceride analysis |
0.0 |
|
|
|
67389 |
66 |
| BN.GK-(D8Got302-D8Got130)/Ox |
plasma triglyceride level |
fasting (between 16 and 18 hours) |
Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 |
blood triglyceride amount |
female |
84.0 days
| 13 |
|
1.2 |
mmol/l |
0.06 |
0.22 |
plasma triglyceride analysis |
0.0 |
|
|
|
67395 |
66 |